Dermatology medications market

Global Dermatology Medications Market Size, by Dermatological Disease (Dermatitis, Acne, Skin Cancer, Psoriasis, Alopecia), Drug Type, Route of Administration, & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

Category: Healthcare and Pharma     ID: IRP1799     Date: Sep, 2020
The global dermatology medications market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million/billion by 2026, at a CAGR of XX% during 2019 to 2026. Scope of global dermatology medications market includes by dermatological disease (Dermatitis, Acne, Skin Cancer, Psoriasis, Alopecia), by drug type (Prescription-Based Drugs, Over-the-Counter Drugs), by route of administration (Topical Administration, Oral Administration, Parenteral Administration), and by region (North America- U.S., Canada; Europe- U.K., France, Germany; Asia-Pacific- China, Japan, India; Latin America- Brazil, Mexico; Middle East & Africa- South Africa, Saudi Arabia).
Dermatology is the branch of medicine which involves research, diagnosis, prevention, and treatment of various cosmetic diseases related to skin, hair, nails, and oral and genital membranes by different investigations and therapies. Dermatology plays a significance role in the field of medicines, as it has been evaluated that around 15% of world population is suffering from common skin diseases, such as skin cancers, warts, fungal infections, dermatitis, psoriasis, acne, atopic eczema, and alopecia. Moreover, various types of medicinal drugs, commonly knowns as dermatological agents are used to treat these skin disorder, which include prescription-based drugs, and over-the-counter drugs, while topical agents are the most commonly used treatment, which can be applied directly to the affected area for the desired effects.
However, the rapid increase in the demand for topical dermatological medications such as anti-inflammatory agents, anti-infective, local anesthetics, cleansers to treat various skin disorders, are the key factors which stimulate the growth of dermatology medications market over the forecast period. Furthermore, it has been evaluated that one in six people, which include infants, teenagers, adults, and the elderly has some type of skin diseases, which are the factors that boost the market growth across the globe. While the 85% of individuals between ages of 12 and 24 are suffering from some form of acne, and the people above 30 are suffering from hair problem which are the key factors in increasing the demand of dermatology medications market across the globe.
However, the lack of awareness of skin disorder and about the drugs are expected to restrain the product demand over the coming years. The shifting preference of people towards routine skin care to maintain skin is the key factor providing opportunities to new entrants to invest in the market. Furthermore, the key players of market are highly focused in manufacturing drugs which are good for hair growth, and can provide rapid treatment to various skin orders. However, North America is the largest consumer of these medications due to increasing awareness of skin disorders, while the Asia Pacific region is expected to have significant growth rate of market due to rapid increase in the skin diseases.
The global dermatology medications market is primarily segmented by dermatological disease, drug type, route of administration, and region.

In terms of dermatological disease, the market is split into:
* Dermatitis
* Acne
* Skin Cancer
* Psoriasis
* Alopecia

In terms of drug type, the market is divided into:
* Prescription-Based Drugs
* Over-the-Counter Drugs

On the route of administration front, the market is segmented into:
* Topical Administration
* Oral Administration
* Parenteral Administration

The market is classified across regions and countries as follows:
* North America- U.S., Canada
* Europe- Russia, U.K., France, Germany, Italy
* Asia-Pacific- China, Japan, India, Australia
* Latin America- Brazil, Mexico
* Middle East & Africa- South Africa, Egypt, Saudi Arabia

Key Market Players:
The key players profiled in the market include:
* Valeant Pharmaceuticals International
* Merck & Co.
* Novartis AG
* LEO Pharma
* Johnson & Johnson
* AstraZeneca
* Amgen Inc.
* Abbvie Inc.
* Radius Healthcare Private Limited
* Nova Indus Pharmaceuticals
* Trumac Healthcare
* Rezicure Pharmaceuticals
* Mil-Spec Industries Corp.
* International Earth Products LLC

These enterprises have been focusing on development strategies, such as expansions, new product launches, agreements & partnerships, and acquisitions to expand their business across the globe.
Key Benefits of the Report:
* Global, regional, country, dermatological disease, route of administration, and drug type market size and their forecast from 2015-2026
* Identification and detailed analysis and insights on key market dynamics, such as drivers, opportunities, restraints, and challenges influencing the growth of the market
* Detailed analysis and insights on industry outlook with market specific PESTLE analysis, Porter’s Five Forces analysis, and Value Chain analysis, to achieve a better understanding of the market and prepare expansion strategies
* Identification and comprehensive analysis of key market players and their market share, detailed financial positions, key products, core competencies, and unique selling points
* Identification and analysis of Key players’ competitive developments and strategic initiatives, such as mergers, joint ventures, sales contracts, and new product introduction in the market
* Expert interviews and their insights on current and future outlook, market shift, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions, dermatological disease, route of administration, and drug type with qualitative and quantitative information and facts
* Identification of the key patents filed in the field of dermatology medications
* Owing to the volatility seen in the market due to the Global COVID-19 pandemic, businesses around the globe wish to know the impact on their market and how this changes the projections for 2020 and the forthcoming years. Orian Research is in talks with seasoned market analysts and key note speakers to understand the impact of COVID 19 on markets and factors that will bring in stability in the foreseeable future

Target Audience:
* Dermatology Medications manufacturer & Technology Providers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.
For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Raw Material Providers
* Government Body & Associations
* Research Institutes

Project Analysis

The project analyst providers critical data support to technical Research and analysis functions may include sed budget tracking financial sed forecasting projects evaluation monitoring, maintanence compliance regulations and performing establisheed fact that a readers. Project it is a long establisheed that a will be ut distracted by that readable content.
  • Improve sales and operations and production planning
  • Determine the right inventory level
  • Optimize the supply chain for perfect order planning
  • Designed we immediately begin to think positively